Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Insulin eye drops for severe refractory chronic ocular graft-versus-host disease ; day:10 ; month:4 ; year:2024 ; pages:1-3
Bone marrow transplantation ; (10.4.2024), 1-3
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-024-02272-9
- URN
-
urn:nbn:de:101:1-2406250921073.945751411424
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tahmaz, V.
- Menghesha, L.
- Stern, M. E.
- Holtick, U.
- Scheid, C.
- Steven, Philipp
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Treatment of ocular graft-versus-host disease with autologous serum eye drops : [kumulative Dissertation]](/assets/placeholder/searchResultMediaUnknown.png)
Treatment of ocular graft-versus-host disease with autologous serum eye drops : [kumulative Dissertation]
Evolving therapeutic paradigms in ocular graft-versus-host disease
Murine Models of Steroid Refractory Graft-versus-Host Disease
A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
A New Treatment for Recalcitrant Neurotrophic Keratopathy of Ocular Graft-Versus-Host Disease with Virus Infection
Treatment of ocular graft-versus-host disease with autologous serum eye drops : [kumulative Dissertation]
Evolving therapeutic paradigms in ocular graft-versus-host disease
Murine Models of Steroid Refractory Graft-versus-Host Disease
A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study
A New Treatment for Recalcitrant Neurotrophic Keratopathy of Ocular Graft-Versus-Host Disease with Virus Infection
Treatment of ocular graft-versus-host disease with autologous serum eye drops : [kumulative Dissertation]
Evolving therapeutic paradigms in ocular graft-versus-host disease
Murine Models of Steroid Refractory Graft-versus-Host Disease
A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination
Angiogenesis in Graft-versus-Host Disease
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study